Concepedia

Author

Shu Tamura

Novartis (Switzerland)

Also Known As

Emiko Hatori, S Tamura, Shu Tamura

16

Publications

4.8K

Citations

9

H-Index

26

Concepts

All Affiliations

Novartis (Switzerland)Brigham and Women's HospitalHyogo Medical UniversityHarvard UniversityOregon Health & Science University
ST

About

Shu Tamura is an author at Novartis (Switzerland) specializing in medicine, cell proliferation, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

3.7K

2

Cell Biology

2

2

3.7K

3

Health Sciences

1

1

25

4

Blood Transplantation

1

1

25

5

Immunology

1

1

25

Shu Tamura

×

6

Publications

4.7K

Citations

6

H-Index

YearCitations

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Brian Druker, Shu Tamura, Elisabeth Buchdunger,

Nature Medicine

1996

3.6K

CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins

Martin Carroll, Sayuri Ohno-Jones, Shu Tamura,

Blood

1997

520

CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins

Martin Carroll, Sayuri Ohno-Jones, Shu Tamura,

Blood

1997

446

The SH2 domain of ABL is not required for factor-independent growth induced by BCR-ABL in a murine myeloid cell line.

Tsukasa Oda, Shu Tamura, Tetsuya Matsuguchi,

PubMed

1995

43

Expression and role of p27kip1 in neuronal differentiation of embryonal carcinoma cells

Kobo Sasaki, Shu Tamura, Hisao Tachibana,

Molecular Brain Research

2000

38

New Imaging Findings in a Patient with Central Nervous System Dysfunction after Bone Marrow Transplantation

Hiroyuki Takatsuka, Takahiro Okamoto, Shinji Yamada,

Acta Haematologica

2000

25

Page 1